64.70
+0.01(+0.02%)
Currency In GBp
Address
Avonbridge House
Chippenham, SN15 2BB
United Kingdom of Great Britain and Northern Ireland
Phone
44 12 4946 6966
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
290
First IPO Date
November 22, 2001
| Name | Title | Pay | Year Born |
| Nicholas John Sedgwick | Chief Executive Officer & Director | 457,710 | 1972 |
| Andrew Timothy Franklin | Chief Financial Officer & Executive Director | 367,148 | 1966 |
| Chris Delafield | Global Marketing Head of Kelo-Cote | 0 | N/A |
| Julie Skinner | Chief People Officer | 0 | N/A |
| Alex Duggan | Chief Commercial & Corporate Development Officer | 0 | N/A |
| Christodoulos Chrysanthou | Group General Counsel & Company Secretary | 0 | N/A |
| Stephen Kidner | Chief Scientific Affairs Officer | 0 | N/A |
| Cora Maeve McCallum | Head of Investor Relations & Corporate Communications | 0 | N/A |
| Rhodri Smith | Head of Sourcing | 0 | N/A |
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
